177 related articles for article (PubMed ID: 870655)
21. [Acute lymphatic leukaemia in children: re-examination after remission of at least five years (author's transl)].
Resch R; Haas H; Michlmayr G
Dtsch Med Wochenschr; 1979 Jul; 104(29):1037-41. PubMed ID: 288556
[TBL] [Abstract][Full Text] [Related]
22. Liver biopsies in psoriatics--complications and evaluation.
Creswell SN; Burrows D
Int J Dermatol; 1980 May; 19(4):217-9. PubMed ID: 7399795
[TBL] [Abstract][Full Text] [Related]
23. Hepatotoxicity of methotrexate in the treatment of psoriasis.
Roenigk HH; Bergfeld WF; St Jacques R; Owens FJ; Hawk WA
Arch Dermatol; 1971 Mar; 103(3):250-61. PubMed ID: 5548272
[No Abstract] [Full Text] [Related]
24. Evaluation of possible chronic hepatotoxicity from methotrexate for psoriasis.
Weinstein GD; Cox JW; Suringa DW; Millard MM; Kalser M; Frost P
Arch Dermatol; 1970 Dec; 102(6):613-8. PubMed ID: 5501902
[No Abstract] [Full Text] [Related]
25. Acute and chronic effects of methotrexate on hepatic, pulmonary, and skeletal systems.
Nesbit M; Krivit W; Heyn R; Sharp H
Cancer; 1976 Feb; 37(2 Suppl):1048-57. PubMed ID: 1062231
[TBL] [Abstract][Full Text] [Related]
26. Hepatic fibrosis with the use of methotrexate for juvenile rheumatoid arthritis.
Keim D; Ragsdale C; Heidelberger K; Sullivan D
J Rheumatol; 1990 Jun; 17(6):846-8. PubMed ID: 2388211
[TBL] [Abstract][Full Text] [Related]
27. A prospective study of the effects of weekly oral methotrexate on liver biopsy.
Warin AP; Landells JW; Levene GM; Baker H
Br J Dermatol; 1975 Sep; 93(3):321-7. PubMed ID: 1103936
[TBL] [Abstract][Full Text] [Related]
28. [Liver changes in children with acute lymphatic leukemia].
Weinmann G; Eckardt S; Lüftner J
Kinderarztl Prax; 1984 Jun; 52(6):271-6. PubMed ID: 6590921
[No Abstract] [Full Text] [Related]
29. Validity of noninvasive markers of methotrexate-induced hepatotoxicity: a retrospective cohort study.
Martyn-Simmons CL; Rosenberg WM; Cross R; Wong T; Smith CH; Barker JN
Br J Dermatol; 2014 Aug; 171(2):267-73. PubMed ID: 24942271
[TBL] [Abstract][Full Text] [Related]
30. ω-3 fatty acids as an adjuvant therapy ameliorates methotrexate-induced hepatotoxicity in children and adolescents with acute lymphoblastic leukemia: A randomized placebo-controlled study.
Elbarbary NS; Ismail EA; Farahat RK; El-Hamamsy M
Nutrition; 2016 Jan; 32(1):41-7. PubMed ID: 26421385
[TBL] [Abstract][Full Text] [Related]
31. Clinical liver disease in patients with rheumatoid arthritis taking methotrexate.
Phillips CA; Cera PJ; Mangan TF; Newman ED
J Rheumatol; 1992 Feb; 19(2):229-33. PubMed ID: 1629819
[TBL] [Abstract][Full Text] [Related]
32. Association between cumulative methotrexate dose, non-invasive scoring system and hepatic fibrosis detected by Fibroscan in rheumatoid arthritis patients receiving methotrexate.
Lertnawapan R; Chonprasertsuk S; Siramolpiwat S
Int J Rheum Dis; 2019 Feb; 22(2):214-221. PubMed ID: 30565876
[TBL] [Abstract][Full Text] [Related]
33. Intensive chemotherapy in children with acute lymphoblastic leukemia (L-2 protocol).
Haghbin M; Tan CC; Clarkson BD; Miké V; Burchenal JH; Murphy ML
Cancer; 1974 Jun; 33(6):1491-8. PubMed ID: 4526012
[No Abstract] [Full Text] [Related]
34. Effect of ursodeoxycholic acid and vitamin E in the prevention of liver injury from methotrexate in pediatric leukemia.
Bordbar M; Shakibazad N; Fattahi M; Haghpanah S; Honar N
Turk J Gastroenterol; 2018 Mar; 29(2):203-209. PubMed ID: 29749328
[TBL] [Abstract][Full Text] [Related]
35. Hepatotoxicity of prolonged methotrexate therapy for rheumatoid arthritis.
Mackenzie AH
Cleve Clin Q; 1985; 52(2):129-35. PubMed ID: 4028418
[No Abstract] [Full Text] [Related]
36. [Long-term toxicity of anti-leukemia therapy].
Valbuena Crespo C
An Esp Pediatr; 1983 Sep; 19 Suppl 19():60-5. PubMed ID: 6581754
[No Abstract] [Full Text] [Related]
37. Methotrexate hepatotoxicity.
West SG
Rheum Dis Clin North Am; 1997 Nov; 23(4):883-915. PubMed ID: 9361160
[TBL] [Abstract][Full Text] [Related]
38. [Methotrexate, liver and rheumatoid arthritis in tropical areas].
Diouf ML; Diallo S; Mbengue M; Moreira-Diop T
Sante; 2001; 11(3):195-200. PubMed ID: 11641084
[TBL] [Abstract][Full Text] [Related]
39. [Incidence of liver diseases in psoriatic patients with special reference to methotrexate therapy].
Moldenhauer E; Dabels J; Diwok K; Leithäuser W; Nowotny P
Dermatol Monatsschr; 1973 Mar; 159(3):242-8. PubMed ID: 4704945
[No Abstract] [Full Text] [Related]
40. Methotrexate and the liver.
Tolman KG; Clegg DO; Lee RG; Ward JR
J Rheumatol Suppl; 1985 Dec; 12 Suppl 12():29-34. PubMed ID: 3831362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
